Oncology/Hematology

Prostate Cancer

Latest AI and machine learning research in prostate cancer for healthcare professionals.

8,435 articles
Stay Ahead - Weekly Prostate Cancer research updates
Subscribe
Browse Categories
Showing 1-20 of 8,435 articles

Interpretable machine learning for individualized survival prediction in node-positive, non-metastatic prostate cancer: a population-based study.

BACKGROUND: Prostate cancer with regional lymph node involvement but no distant metastasis (N1M0) has heterogeneous prognosis. This study aimed to develop and validate an interpretable machine learning model for predicting cancer-specific survival (CSS). METHODS: Data from 18,287 N1M0 patients (2000-2022) in the SEER database were divided into training (n = 4780), internal testing (n = 1193), and ...

Sep 3 2026 42690326

Deep learning auto-contouring of target and organs-at-risk on post-catheter implant CT images for prostate HDR brachytherapy.

BACKGROUND: Accurate delineation of the prostate and surrounding organs-at-risk (OARs) is essential for HDR prostate brachytherapy. Manual contouring on post-catheter CT images is time-consuming and prone to variability due to artifacts and anatomical deformation from the implanted brachytherapy catheters. PURPOSE: To develop and validate a 3D deep learning autosegmentation model for prostate and ...

Sep 1 2026 42613795
Machine learning-based classification model to distinguish tumor and tumor-free samples using synthetic plasma proteomic dataset.

BACKGROUND: Tumor-Specific Peptides (TSPs) and Tumor-associated Overexpressed Proteins (TOPs) are promising biomarkers for cancer diagnosis and monito...

Sep 1 2026 42664122
Apparent diffusion coefficient radiomics for differentiating benign and malignant PI-RADS 3-5 prostate lesions: external validation.

PURPOSE: To develop and externally validate a simplified apparent diffusion coefficient (ADC)-based MRI radiomics model for differentiating benign and...

Aug 31 2026 42675219
Multimodal artificial intelligence in prostate cancer: integrating multiparametric MRI with clinicopathological, molecular, and functional imaging data.

Multimodal artificial intelligence (AI) is reshaping prostate cancer imaging by moving beyond MRI-only algorithms toward models that integrate multipa...

Aug 24 2026 42635792
Automatic treatment planning using reinforcement learning for high-dose-rate prostate brachytherapy.

Purpose.In high-dose-rate (HDR) prostate brachytherapy procedures, needle placement solely relies on physician experience. We investigated the feasibi...

Aug 19 2026 42562017
A comprehensive framework for multi-class prostate cancer classification using biparametric MRI: a multi-center retrospective study.

OBJECTIVES: Accurate pre-biopsy or preoperative diagnosis and risk stratification of prostate cancer remain challenging. This study aimed to develop a...

Aug 17 2026 42606778
Accurate and noninvasive prostate cancer detection using plasma-derived extracellular vesicle RNA.

Prostate cancer (PCa) is the most commonly diagnosed noncutaneous malignancy in men and a leading cause of cancer-related death worldwide. Its clinica...

Aug 7 2026 42566681
Machine learning-based clinical models for prediction of urinary incontinence after robot-assisted laparoscopic radical prostatectomy.

OBJECTIVE: To investigate risk factors for urinary incontinence (UI) after robot-assisted laparoscopic radical prostatectomy (RARP) using interpretabl...

Jul 21 2026 42481990
Artificial Intelligence Versus Conventional Methods for NCCN Risk Stratification in Localized Prostate Cancer (2020-2025): A Systematic Review.

BACKGROUND AND OBJECTIVE: Accurate risk stratification in localized prostate cancer is essential for guiding treatment decisions. Conventional Nationa...

Jul 21 2026 42483695
A serum-clinical composite model for prostate cancer diagnosis: multicenter validation and CRISPR/Cas13a-based detection.

BACKGROUND: Avoidable prostate biopsies remain a persistent weakness of prostate specific antigen (PSA)- and imaging-led prostate cancer (PCa) diagnos...

Jul 17 2026 42565148
Evaluating Risk Factors Associating With Late Recurrence After Low-Dose-Rate Brachytherapy for Prostate Cancer Using Machine Learning.

BACKGROUND: The Phoenix definition is widely used to define biochemical recurrence (BCR) after radiation therapy for prostate cancer; however, a defin...

Jul 16 2026 42462134
Development of a predictive marker panel for the individualised bDMARD therapy of psoriatic arthritis: protocol for a prospective observational study (Integrate-PsA).

INTRODUCTION: Psoriatic arthritis is a chronic inflammatory disease that can affect the axial skeleton as well as the joints and enthesis. Following t...

Jul 15 2026 42463211
fAI-BRO: a multimodal AI decision-support system to address diagnostic delay in fibromyalgia syndrome.

OBJECTIVE: To evaluate the diagnostic accuracy and patient acceptability of fAI-BRO (Fibromyalgia AI-Based Rheumatology Observer), a multimodal artifi...

Jul 13 2026 42442924
Clinical-Radiomics Model Based on T2-Weighted and Diffusion-Weighted Magnetic Resonance Images on Predicting "Double Gray Zone" Prostate Cancer of PSA and PI-RADS.

OBJECTIVES: This study aimed to develop a clinical-radiomics model based on T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) to improve...

Jul 10 2026 42431796
Artificial intelligence-enabled MRI surveillance of prostate cancer: integrating PRECISE v2, PI-QUAL, and longitudinal biomarkers-a narrative review.

Active surveillance (AS) is widely used for men with low-risk and selected favorable intermediate-risk prostate cancer, but pathways remain heterogene...

Jul 4 2026 42400610
Intraoperative technological advances and new frontiers in precision glioma surgery.

BACKGROUND: Diffuse gliomas remain among the most surgically challenging tumors, characterized by their infiltrative nature, proximity to eloquent bra...

Jul 4 2026 42400691
Evolving role of biomarkers beyond prostate‑specific antigen in refining prostate cancer screening: From blood‑based tests to urinary and genetic markers (Review).

Prostate‑specific antigen (PSA) screening reduces prostate cancer (PCa) mortality but is limited by overdiagnosis and poor specificity for clinically ...

Jul 3 2026 42396659
Clinical Variable-Based Machine Learning for Predicting Early mCRPC Using Exclusively Clinical Variables: Development and Multicenter External Validation.

BACKGROUND AND OBJECTIVE: Metastatic hormone-sensitive prostate cancer (mHSPC) exhibits heterogeneous progression patterns, with early progression to ...

Jul 2 2026 42391467
Browse Categories